Literature DB >> 8050537

Is severe arterial hypoxaemia due to hepatic disease an indication for liver transplantation? A new therapeutic approach.

R Rodriguez-Roisin, M J Krowka.   

Abstract

Severe arterial hypoxaemia or deteriorating pulmonary oxygenation due to HPS appears to be reversible within months of orthotopic liver transplantation. Due to the apparently poor prognosis in these patients, such abnormal oxygenation may, indeed, be considered an indication for liver transplantation in selected clinical situations. The pretransplant distinction between HPS and pulmonary hypertension as a reason for arterial hypoxaemia is essential, however, in that different outcomes appear to exist. Further prospective studies of patients with pulmonary vascular complications of liver disease are desperately needed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8050537

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  13 in total

1.  Sustained low diffusing capacity in hepatopulmonary syndrome after liver transplantation.

Authors:  Graciela Martínez-Palli; Federico P Gómez; Joan A Barberà; Miquel Navasa; Josep Roca; Robert Rodríguez-Roisin; Felip Burgos; Conchi Gistau
Journal:  World J Gastroenterol       Date:  2006-09-28       Impact factor: 5.742

2.  Pulmonary vascular disease in Gaucher disease: clinical spectrum, determinants of phenotype and long-term outcomes of therapy.

Authors:  Sarah Michelman Lo; Jun Liu; F Chen; G M Pastores; J Knowles; M Boxer; Kirk Aleck; Pramod K Mistry
Journal:  J Inherit Metab Dis       Date:  2011-03-29       Impact factor: 4.982

3.  The role of garlic in hepatopulmonary syndrome: a randomized controlled trial.

Authors:  Binay K De; Deep Dutta; Subrata K Pal; Subhabrata Gangopadhyay; Sumanta Das Baksi; Adyapad Pani
Journal:  Can J Gastroenterol       Date:  2010-03       Impact factor: 3.522

4.  Surgical closure of large splenorenal shunt may accelerate recovery from hepato-pulmonary syndrome in liver transplant patients.

Authors:  Yan-Jun Shi; Patrick Mckiernan; Kyle Soltys; George Mazariegos; Wei-Lin Wang
Journal:  World J Emerg Med       Date:  2020

Review 5.  Cardiopulmonary complications in chronic liver disease.

Authors:  Soren Moller; Jens H Henriksen
Journal:  World J Gastroenterol       Date:  2006-01-28       Impact factor: 5.742

6.  Arterial hypoxaemia in cirrhosis: fact or fiction?

Authors:  S Møller; J Hillingsø; E Christensen; J H Henriksen
Journal:  Gut       Date:  1998-06       Impact factor: 23.059

7.  Diagnostic challenge of hepatopulmonary syndrome in a patient with coexisting structural heart disease.

Authors:  Jorge M Hurtado-Cordovi; Seth Lipka; Jaspreet Singh; Ghulamullah Shahzad; Paul Mustacchia
Journal:  Case Reports Hepatol       Date:  2011-09-18

Review 8.  Review article: Update on current and emergent data on hepatopulmonary syndrome.

Authors:  Stergios Soulaidopoulos; Evangelos Cholongitas; George Giannakoulas; Maria Vlachou; Ioannis Goulis
Journal:  World J Gastroenterol       Date:  2018-03-28       Impact factor: 5.742

9.  Left Ventricular Dilation and Pulmonary Vasodilatation after Surgical Shunt for Treatment of Pre-Sinusoidal Portal Hypertension.

Authors:  Orlando Luis de Andrade Santarém; Roberto de Cleva; Flávia Megumi Sasaya; Marianna Siqueira de Assumpção; Meive Santos Furtado; Alfonso Julio Guedes Barbato; Paulo Herman
Journal:  PLoS One       Date:  2016-04-27       Impact factor: 3.240

10.  Cryptogenic Cirrhosis and Hepatopulmonary Syndrome in a Boy with Hepatic Hemangioma in Botswana: A Case Report and Review of the Literature.

Authors:  Francis Msume Banda; Jeremy S Slone; Alan Anderson; Marisa Beretta; Priya Walabh; Jerome Loveland; Simon Nayler; Farirai Fani Takawira
Journal:  Case Rep Pediatr       Date:  2017-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.